59 studies were found. Here are studies 1 to 50.

1.		Recruiting	Antineoplaston Therapy in Treating Children With Brain Tumors Condition: childhood brain tumor
2.		Recruiting	Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma Conditions: low-grade childhood cerebral astrocytoma; recurrent childhood cerebral astrocytoma
3.		Recruiting	Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors Conditions: childhood brain tumor; childhood meningioma
4.		Recruiting	Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors Conditions: untreated childhood supratentorial primitive neuroectodermal tumors; recurrent childhood supratentorial primitive neuroectodermal tumors
5.		Recruiting	Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma Conditions: high-grade childhood cerebral astrocytoma; recurrent childhood cerebral astrocytoma
6.		Recruiting	Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System Condition: childhood rhabdoid tumor of the central nervous system
7.		Recruiting	Antineoplaston Therapy in Treating Children With Visual Pathway Glioma Conditions: untreated childhood visual pathway glioma; recurrent childhood visual pathway glioma
8.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer Condition: Head and Neck Cancer
9.		Recruiting	Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma Conditions: advanced malignant mesothelioma; recurrent malignant mesothelioma
10.		Recruiting	Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma Conditions: recurrent adult brain tumor; adult anaplastic astrocytoma
11.		Recruiting	Antineoplaston Therapy in Treating Patients With Brain Stem Glioma Conditions: recurrent adult brain tumor; adult brain stem glioma; untreated childhood brain stem glioma; recurrent childhood brain stem glioma
12.		Recruiting	Antineoplaston Therapy in Treating Patients With Brain Tumors Conditions: ACTH-producing pituitary tumor; TSH producing pituitary tumor; adult brain tumor
13.		Recruiting	Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus Conditions: stage IV esophageal cancer; recurrent esophageal cancer; Adenocarcinoma of the Esophagus
14.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine Conditions: small intestine adenocarcinoma; recurrent small intestine cancer
15.		Recruiting	Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin Conditions: adenocarcinoma of unknown primary; recurrent carcinoma of unknown primary
16.		Recruiting	Antineoplaston Therapy in Treating Patients With Colon Cancer Conditions: stage IV colon cancer; recurrent colon cancer; adenocarcinoma of the colon
17.		Recruiting	Antineoplaston Therapy in Treating Patients With Ependymoma Conditions: adult ependymoma; newly diagnosed childhood ependymoma; recurrent childhood ependymoma; adult anaplastic ependymoma
18.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme Condition: adult glioblastoma
19.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme Conditions: recurrent adult brain tumor; adult glioblastoma multiforme
20.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma Conditions: recurrent adult brain tumor; adult well-differentiated mildly and moderately anaplastic astrocytoma; adult juvenile pilocytic astrocytoma; ...
21.		Recruiting	Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
22.		Recruiting	Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma Conditions: contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; stage IV mantle cell lymphoma; ...
23.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Meningioma Conditions: recurrent adult brain tumor; adult malignant meningioma
24.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer Conditions: stage IV colon cancer; recurrent colon cancer; adenocarcinoma of the colon
25.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
26.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma Conditions: regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
27.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors Conditions: metastatic childhood soft tissue sarcoma; recurrent childhood soft tissue sarcoma; metastatic tumors of the Ewing's family; ...
28.		Recruiting	Antineoplaston Therapy in Treating Patients With Multiple Myeloma Conditions: refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
29.		Recruiting	Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy Conditions: Merkel Cell Carcinoma; Islet Cell Carcinoma; Neuroendocrine Carcinoma; Pituitary Tumor
30.		Recruiting	Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma Condition: adult non-Hodgkin's lymphoma
31.		Recruiting	Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma Condition: primary central nervous system lymphoma
32.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Primary Liver Cancer Conditions: stage IV childhood liver cancer; recurrent childhood liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer
33.		Recruiting	Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors Condition: adult brain tumor
34.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
35.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Recurrent or Refractory High-Grade Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma Conditions: adult Burkitt's lymphoma; adult immunoblastic large cell lymphoma; adult lymphoblastic lymphoma
36.		Recruiting	Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas Conditions: recurrent adult brain tumor; Mixed Gliomas
37.		Recruiting	Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma Conditions: recurrent adult brain tumor; adult anaplastic oligodendroglioma; Adult Oligodendroglioma
38.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia Conditions: refractory plasma cell neoplasm; Waldenstrom's Macroglobulinemia
39.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; Bronchoalveolar Cell Lung Cancer
40.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer Conditions: recurrent non-small cell lung cancer; Squamous Cell Lung Cancer; stage IV non-small cell lung cancer
41.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Refractory or Recurrent Intermediate-Grade Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma Conditions: adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; grade 3 follicular lymphoma
42.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
43.		Recruiting	Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma Conditions: recurrent adult brain tumor; adult anaplastic astrocytoma
44.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma Conditions: stage III adult soft tissue sarcoma; stage IV adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; ...
45.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage III ovarian germ cell tumor; ...
46.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer Conditions: adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
47.		Recruiting	Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer Conditions: adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
48.		Recruiting	Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer Conditions: stage IV adrenocortical carcinoma; recurrent adrenocortical carcinoma
49.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva Conditions: stage IV cervical cancer; recurrent cervical cancer; stage IV vulvar cancer; recurrent vulvar cancer
50.		No longer recruiting	Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer; Renal Cell Adenocarcinoma; ...